Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gary, although I don't talk about it, I'm fully aware and excited for this fibromyalgia/pain study, phase 2. The company is a sleeping giant, and again is very undervalued compared to its peers.
Think bigger then Teva.
Cherry, with all due respect I'm not going to send the company an email over this cream or others. There will be more creams over the next 25 years that come and go. Owcp cream scientifically proved 70 percent improvement in biological markers, has any one else's product done that? It's also moving into phase 2 trials and is completing there safety study this quarter, are these other creams doing that too? Could they be selling right now at least cosmetically? I would guess upon completion of there safety study that could happen. Mediq has been replaced by someone better with more requirements to sell there cream, that's the current hold up IMO.
That's great, but if he goes and the same takes his place then nothing will happen. My message to my senators in Minnesota has been this:
Instead of congress more or less putting Jeff Session's actions down or condemning what he's done, how about a proactive solution that takes care of the problem. It's time for the house and senate to have a serious conversation on legalizing marijuana that 64 percent of Americans are currently in favor of. Condemning Sessions actions makes me feel good to hear, but does nothing to solve the problem. Also duly note, there has been a very democratic approach to the legalization in every state through voting yes or no to legalize marijuana. One individual trampling over the rights of many and congress condemning it, but allowing it, puts you and Sessions in the same category. It's time to take a stand for marijuana legalization and most importantly the democratic process I and Americans live in.
I'm actually interested to see how the last hour or two trades. A Monday news event could happen. If this spikes in the last hour or two I would expect just that. That's just my opinion.
I'm heading out to go ice fishing in -10 weather... . Will check back close to closing to see if my thought process is right.
That works two ways, puking out garbage can make it worse for stock owners too.
OWCP plan to sell our cream and tablets has been Germany first, then the rest of Europe in countries that have passed mmj. The second was to sell in Canada, where again, it is legalized. There has been talk there is a big market in Asia they are going after also after Europe.
As far as the US goes, there policy has been California first, or other highly populated legal mmj states. But after Europe and Canada.
We are also based in Isreal where the actions of the US means nothing to us other then our piece of the pie maybe isn't as big as it could've been.
Honestly, yesterday's trading for many mmj stocks, proves how uniformed investors are yet about what there buying.
It wouldn't even hurt for companies such as OWCP to come out and make a statement why the actions of Sessions does not change the overall business plan to calm investors, and put that statement right on there website for all to see until our US government legalizes it.
Bring on the Canadian exchange OWCP, it's time to make it official!
https://www.forbes.com/sites/trangho/2018/01/04/jeff-sessions-ignites-marijuana-stock-sell-off-but-fuels-canadian-cannabis-longterm/
I read that article earlier, it clearly says by law the medical side is still protected!
Trump has a grand opportunity to show the public he respects the democratic process that was voted on by the people in each state that has made it legal. This will have a ripple effect in November elections if he does not respond in a way that supports states rights!
I will be looking for some crazy, off the Wall tweet from him over the next few days.
Yes you have ChuckBits, didn't mean to steal your thunder ha ha
You are absolutely right, congress has to act now.
It's hard to see that the Jeff Sessions news today was a good thing...... but, now congress has been forced to act. Mark this post, there will be a huge movement to at the very least legalize mmj. Nancy Pelosi today says congress must act now:
Also, again, this is why I'm invested in a company in Isreal where the laws are friendly and that plan to sell in Europe and Canada first.
Crosslisting can typically solve the issue your speaking of with mm. And maybe that's part of the reason the company decided to try to crosslist. With that being said, are you reinvesting upon that news?
I think a wash sale pertains to buying back in the company you sold and or companies alike. So if you invested back into a mmj again I'm not sure how that will work for you. You may want to ask your tax man.
TSX announcement next week will take care of that.
This is the exact reason you invest in OWCP! We are across the pond, jeff Sessions has zero jurisdiction over us! We can still sell our products across the world no matter what the US policy is!
Couple things here. After a conversation with an individual I know from TSX I do now forsure believe we can be on there and fully expect that to happen in Q1. After watching the L2 the last two weeks it isn't a wonder they wanted to crosslist.
The other thing with mediq not on there website I would think a " better" distribution deal has been struck and should be announced in q1. The safety trial of the cream was probably there requirement. Interesting note, they moved forward with the safety trial of there tablet rather suddenly. I suspect a deal has been struck there too upon two successful safety trials. Two products heading to market in 2018 possibly? Pure speculation people, but it does add up.
That was definatley a strange one. You should take note they never denied they were talking to pfizer. They denied they were the source or knew the source of the article.
Two products heading into phase 2 trials, both of which they are going to schedule a pre IND meeting with the FDA. Phase 2 trials will take place in Isreal where the research can get done for pennies on the dollar compared to in the US. An Efficacy study being done on Humans, a big step up from the efficacy study done on biological markers that they completed and announced a 70 percent improvement on. Which in the medical world, is considered a possible breakthrough as they stated.
A MM study ongoing which they are scheduled to start a clinical study on in second half of 2018. This study is designed to head to orphan drug.
1 safety study currently in progress on the cream, and another to start in q2 on our tablet.
Leader ship has changed this summer, with definatley a more qualified team in this field.
I will remain long for the above reasons and more!
Your right, but failed to mention the safety study being done on the tablet just a few months after the cream. Think of the implications to this stock price if JV/partnerships/licensing is announced after the successful safety study of the cream. Investors will realize the same thing could happen upon safety study completion of the tablet..... there will be down days, but more explosive upwards days because of real catalysts about to start. I think we see plenty of news to kick off this new year!
In my opinion, we are currently one of the most undervalued mmj biopharma stocks out there. Expect a wave of people who feel left out of the run to flood to this stock for just that reason.
Clay can post the same chart 3 times a day on the same board. I'm not sure why, cause his first half hour candlestick is equally as boring as the second and third time it plays over:) but I will say this fact to clear up Clay Trader on this board:
Clay started posting on here in November last year when it was trading at .09 and .10 cents. He kept posting right up to the high of over $3 in March, and continued at a slower pace as it fell. So to say any run will be over by him posting is completely not true and history proves that.
Here was the 8-k addressing the Pfizer article:
http://app.quotemedia.com/data/downloadFiling?webmasterId=102426&ref=11794106&type=HTML&symbol=OWCP&companyName=OWC+Pharmaceutical+Research+Corp&formType=8-K&formDescription=Report+of+unscheduled+material+events+or+corporate+changes.&dateFiled=2017-09-12
Has OWCP ever mentioned in previous 8-k's there tablet would be used as a non- opioid use? I know we've probably all thought it, I just don't recall them ever linking the two like they did in there last 8-k. This could be a pretty big deal due to the recent push to stop the opioid crisis.
Commenting on this milestone, Dr. Yehuda Baruch Director of Research and Regulatory Affairs at OWC stated “We greatly look forward to introducing this breakthrough tablet to the marketplace after completing our testing. The preliminary results with the Tablet have been promising and we are eager to provide patients suffering from debilitating chronic conditions with effective non-opioid solutions”.
We could be hearing news on this in the near future:
https://www.intivabiopharma.com/single-post/2017/08/01/Intiva-BioPharma-Submits-a-Request-to-the-FDA-for-a-Pre-Investigational-New-Drug-Meeting-for-a-Pharmaceutical-Product-for-Use-in-the-Acute-Treatment-During-and-Immediately-Following-Exposure-to-Nerve-Agents
Happy new year to you and all! Let's get this party going next year for OWCP and SKOL Vikings!
I should bring one last thing to your attention regarding share structure of these two companies we are comparing. Owcp has roughly 27 million more OS shares then CNBX. But the big difference is in the float, where Owcp has close to 90 million and CNBX has 30 million.... ironically a third, and as you said we are trading at a third of there price. So when people come to buy, that one in theory will move faster upwards then OWCP. Again though, at the end of the day its products that will make the longterm difference, and we have just that coming for 2018 and beyond.
That's a great post and you could very well be right. Hirsch definitely brings trust and confidence to the table. I'm heading to the Wall Street conference and will be more then happy to share with you what I hear. Although, technically, they can't say anything big at it without a pr or 8-k before hand. But they can talk about where they see the company in the upcoming years.
Product/revenue could be a driver of it. If there's institutional investors in them can also make a difference as owcp has very few institutional investors. I own a fair amount of Gwph and CNBX also, but own the biggest share of OWCP. I own it that way because I've always thought we are deeply undervalued compared to these other companies. I think this will all change after Q1.
We trade weeks sometimes over month or two behind them companies. Check out previous runs and then compare to ours, I think you will agree. They all have lower floats which move them up quicker, although imlff is close to our structure.
Also, look at what there trying to cure or at least help people with. Owcp has created a cream to help with psriosis, that's really fairly boring to an investor. What are them other companies trying to help? Is it kind of exciting? That could be the difference a little too as crazy as this may all sound. I know what two of them are doing, but not the others.
Boring products are true work horses in the longterm for stocks, you have nothing to worry about if your here longterm. Also if this is a " breakthrough " product as owcp stated it will not stay boring for long!
I will buy you a beer some day for being the most honest day trader! Haha
Thank you for giving a real time update on these items, I really appreciate it and I think other investors on here also do.
Just one or two people making some last minute tax season selling drove this down hard. That's over now obviously...... now we just need to fill that gap I hear so much about! GWPH gap never did fill from a year and half ago, that's because of there efficacy results from phase 2 and an announcement of phase three trials underway that drove it from $38.46 to $84.05. A 119 percent increase in price one day.
Does any of this talk resemble the OWCP website? Phase 2 efficacy tests done on Humans, not biological markers like the last study done on the cream. There will be an efficacy test on cream and the tablet done over the next 2 years. The pps will grind up over this period of time.
Gwph market cap was at $800,000,000 before the gap up, and about 1.7 billion after the results. This is equivalent to $5 pps in owcp before hand and over $12 after the results of just one of our products, not both mind you if you want to compare apple to apples.
Keep in mind this pps of GWPH was at a time in the world in what I consider an unfavorable environment for mmj.
For the above reasons, I see $4 to $7 pps in owcp very sustainable in 2018. I'm being conservative here, but that's In my nature.
It's my opinion real news will start the week of January 8th. That would fit in nicely with the way this has been trading recently. When I say " real" news. The kind of news that makes the pps climb to new highs and stick there until the next real news event comes and takes it to another level. Just my opinion.
One may be surprised at how high this could go real quick. Investors like excitement. If you look at like Campbell soup, Bank of America, or Cummings, they are a boring stock to own and can be seriously undervalued at times.
To put it in perspective, would you buy soup stock, Or a drug that could stop the reactions of nerve gas agents with mmj.....
I'm telling you.... this stock could go viral upon an announcement of orphan drug acceptance using mmj to stop the reactions of nerve gas....... it's exciting, people buy exciting stuff!!!
Cramer said to buy it, about 15 months ago in one of his episodes........ they just have more public exposure, that's why there higher.
I could handle all that forsure! OWCP has big and real news in Q1 and I'm patiently waiting to hear all about it! Human efficacy study to take place and another one after that to soon follow. Human efficacy results ultimately are what can really drive a stock to new levels. This is with cream and the tablet, were not even talking MM study in orphan drug. I'm holding into 2020. I will say Q1 and Q2 are important for shareholder confidence. Hirsch has had nearly 6 months to put things in order, I expect real news that fundelmentally drives the stock price from here on out!
Wow! That's the first I've seen of that! That is huge!
You are correct! That's why Owcp and NTVA can and are taking that same path! I'm not sure the outcome though, if both these companies will have to fight them. NTVA has a billionaire on there advisory board so I'm hopeful his money and power can help persuade ranking officials away from the path you mentioned Gwph is taking!